Patent Assignment
Reel/Frame 061916/0493
Release of Security Interest
Recorded: 2022-11-10
Pages: 10
Assignor
OXFORD FINANCE LUXEMBOURG S.À R.L
Executed: 2022-11-08
Assignees
IMMUNOCORE LIMITED
92 PARK DRIVE, MILTON PARK, ABINGDON, OXON, OX14 4RY, UNITED KINGDOM
IMMUNOCORE LLC
SIX TOWER BRIDGE, 181 WASHINGTON STREET, SUITE 540, CONSHOHOCKEN, PENNSYLVANIA, 18422
IMMUNOCORE COMMERCIAL LLC
SIX TOWER BRIDGE, 181 WASHINGTON STREET, SUITE 540, CONSHOHOCKEN, PENNSYLVANIA, 18422
Covered Properties
(59)
Soluble T Cell Receptor
Single Chain Recombinant T Cell Receptors
Modified Soluble T Cell Receptor
Cells Expressing a Modified T Cell Receptor
Soluble T Cell Receptors
T Cell Receptor Display
Bifunctional Polypeptides
Non-naturally occurring T cell receptors
Cells Expressing Modified T Cell Receptor
Nucleic Acid Molecules Encoding Non-Naturally Occurring T Cell Receptors and Cells Thereof
T Cell Receptor Display
T Cell Receptor Display
Method for Predicting the Off-Target Biding of a Peptide Which Binds to a Target Peptide Presented by a Major Histocompatibility Complex
Tcr Libraries
Application:
15/262,160 →
Publication:
US 2017/0051036
Tcr Libraries
Tcr Libraries
Peptides Derived from Actin-Like Protein 8 (ACTL8)
Peptides
Application:
15/777,149 →
Publication:
US 2018/0327466
Peptides Derived from Kita-Kyushu Lung Cancer Antigen (KKLC1, CT83, CXORF61) and Complexes Comprising Such Peptides Bound to Mhc Molecules
Peptides Derived from Achaete-Scute Homolog 2 (ASCL2), Complexes Comprising Such Peptides Bound to Mhc Molecules
Application:
15/777,163 →
Publication:
US 2018/0355006
Peptides Derived from Prostate Specific Antigen (KLK3) and Complexes Comprising Such Peptides Bound to Mhc Molecules
Application:
15/777,613 →
Publication:
US 2018/0339028
Peptides Derived from Lengsin (Lgsn), Complexes Comprising Such Peptides Bound to Mhc Molecules
Peptides Derived from Homeobox Protein B13 (Hox-B13) and Complexes Comprising Such Peptides Bound to Mhc Molecules
Application:
15/777,875 →
Publication:
US 2018/0339029
Peptides
Application:
15/777,877 →
Publication:
US 2018/0346545
Peptides from NPSR1
Application:
15/777,880 →
Publication:
US 2018/0339027
Peptides Derived from Melanoma-Associated Antigen C2 (MAGEC2) and Uses Thereof
Application:
15/777,883 →
Publication:
US 2018/0346511
Peptides Derived from Prorelaxin H1 (RLN1)
Application:
15/778,177 →
Publication:
US 2018/0340016
Peptides Derived from Sarcoma Antigen 1 (SAGE1) and Complexes Comprising Such Peptides Bound to Mhc Molecules
Application:
15/778,179 →
Publication:
US 2018/0346536
Peptides Derived from Solute Carrier Family 45 Member 2 (SLC45A2) and Uses Thereof
Application:
15/778,199 →
Publication:
US 2018/0346517
Peptides
Application:
15/778,204 →
Publication:
US 2018/0340018
Peptides Derived from Transient Receptor Potential Cation Channel Subfamily M Member 1 (TRPM1), Complexes Comprising Such Peptides Bound to Mhc Molecules
T Cell Receptors Specific for the Ny-Eso-1 Tumor Antigen-Hla-a*02 Complex
Peptides
Application:
16/084,883 →
Publication:
US 2019/0083591
Engineered Immune-Mobilizing T-Cell Receptors with Enhanced Affinity for Hiv-1 Gag
T Cell Receptors
Peptides of Bromodomain Testis-Specific Protein (Brdt)
Application:
16/097,582 →
Publication:
US 2019/0153053
Bifunctional Polypeptides
Application:
16/151,144 →
Publication:
US 2019/0247512
Dosing Regimen for GP100-Specific Tcr - Anti-CD3 Scfv Fusion Protein
Peptides
Application:
16/347,384 →
Publication:
US 2021/0115099
Bifunctional Polypeptides
Bifunctional Polypeptides
Bifunctional Polypeptides
T Cell Receptors
Peptides
Application:
16/938,263 →
Publication:
US 2021/0054080
A Method of Detecting MAGEA4
Application:
16/979,146 →
Publication:
US 2020/0400674
Peptides Derived from P Antigen Family Member 2 (PAGE2)
Application:
16/985,058 →
Publication:
US 2021/0017250
Peptides
Application:
16/985,061 →
Publication:
US 2021/0017227
Peptides
Application:
16/988,425 →
Publication:
US 2021/0032301
Peptides
Application:
16/988,431 →
Publication:
US 2021/0017228
Peptides Derived from Transient Receptor Potential Cation Channel Subfamily M Member 1 (TRPM1), Complexes Comprising Such Peptides Bound to Mhc Molecules
Application:
16/988,523 →
Publication:
US 2021/0093732
Peptides from PIWIL1
Application:
16/994,399 →
Publication:
US 2021/0061857
Peptides Derived from Actin-Like Protein 8 (ACTL8)
Application:
16/997,731 →
Publication:
US 2021/0145936
Peptides Derived from Kallikrein 4
Application:
16/998,945 →
Publication:
US 2021/0047629
Peptides
Application:
17/010,653 →
Publication:
US 2021/0054045
Peptides
Application:
17/013,228 →
Publication:
US 2021/0054036
Claudin-6 Peptides
Application:
17/017,444 →
Publication:
US 2021/0061874
Peptides of PAGE5
Application:
17/017,457 →
Publication:
US 2021/0054037
Peptides of Bromodomain Testis-Specific Protein (Brdt)
Application:
17/031,691 →
Publication:
US 2021/0101949
Peptides Derived from Kita-Kyushu Lung Cancer Antigen (KKLC1, CT83, CXORF61) and Complexes Comprising Such Peptides Bound to Mhc Molecules
Application:
17/065,509 →
Publication:
US 2021/0121526
Related Assignments
(25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Sep 1, 2004
From: JAKOBSEN, BENT KARSTEN; GLICK, MEIR
To: AVIDEX LIMITED
Reel/Frame 015800/0973 →
Assignment of Assignor's Interest
Aug 29, 2005
From: JAKOBSEN, BENT KARSTEN; GLICK, MEIR
To: AVIDEX LIMITED
Reel/Frame 016921/0249 →
Assignment of Assignor's Interest
Apr 5, 2006
From: JAKOBSEN, BENT KARSTEN; GLICK, MEIR
To: AVIDEX LIMITED
Reel/Frame 017958/0155 →
Change of Name
Nov 12, 2007
From: AVIDEX LIMITED
To: MEDIGENE LIMITED
Reel/Frame 020097/0212 →
Change of Name
May 19, 2008
From: AVIDEX LIMITED
To: MEDIGENE LIMITED
Reel/Frame 020965/0880 →
Change of Name
Aug 12, 2008
From: AVIDEX LIMITED
To: MEDIGENE LIMITED
Reel/Frame 021370/0378 →
Assignment of Assignor's Interest
Jan 8, 2009
From: MEDIGENE LIMITED
To: IMMUNOCORE LIMITED
Reel/Frame 022076/0044 →
Assignment of Assignor's Interest
Apr 13, 2009
From: JAKOBSEN, BENT KARSTEN
To: IMMUNOCORE LIMITED
Reel/Frame 022538/0727 →
Change of Name
Feb 20, 2012
From: AVIDEX LIMITED
To: MEDIGENE LIMITED
Reel/Frame 027731/0117 →
Assignment of Assignor's Interest
Feb 20, 2012
From: JAKOBSEN, BENT KARSTEN; GLICK, MEIR
To: AVIDEX LIMITED
Reel/Frame 027731/0073 →
Assignment of Assignor's Interest
Mar 23, 2012
From: MEDIGENE LIMITED
To: IMMUNOCORE LIMITED
Reel/Frame 027915/0868 →
Change of Name
Mar 23, 2012
From: AVIDEX LIMITED
To: MEDIGENE LIMITED
Reel/Frame 027915/0667 →
Assignment of Assignor's Interest
Mar 23, 2012
From: JAKOBSEN, BENT KARSTEN; ANDERSEN, TORBEN BENT; MOLLOY, PETER EAMON; LI, YI
To: AVIDEX LIMITED
Reel/Frame 027915/0576 →
Assignment of Assignor's Interest
Apr 5, 2012
From: JAKOBSEN, BENT KARSTEN; VUIDEPOT, ANNELISE BRIGITTE; LI, YI
To: IMMUNOCORE LIMITED
Reel/Frame 027995/0465 →
Assignment of Assignor's Interest
Dec 17, 2012
From: JAKOBSEN, BENT KARSTEN
To: IMMUNOCORE LIMITED
Reel/Frame 029482/0432 →
Assignment of Assignor's Interest
Feb 7, 2013
From: JAKOBSEN, BENT KARSTEN; HARWOOD, NAOMI; LIDDY, NATHANIEL ROSS
To: IMMUNOCORE LIMITED
Reel/Frame 029769/0388 →
Assignment of Assignor's Interest
Jul 18, 2013
From: IMMUNOCORE LIMITED
To: ADAPTIMMUNE LIMITED; IMMUNOCORE LIMITED
Reel/Frame 030824/0150 →
Assignment of Assignor's Interest
Jul 18, 2013
From: IMMUNOCORE LIMITED
To: ADAPTIMMUNE LIMITED; IMMUNOCORE LIMITED
Reel/Frame 030824/0190 →
Assignment of Assignor's Interest
Apr 10, 2014
From: JAKOBSEN, BENT KARSTEN; ANDERSEN, TORBEN BENT; MOLLOY, PETER EAMON; LI, YI
To: AVIDEX LIMITED
Reel/Frame 032643/0399 →
Change of Name
Apr 10, 2014
From: AVIDEX LIMITED
To: MEDIGENE LIMITED
Reel/Frame 032643/0481 →
Assignment of Assignor's Interest
Apr 11, 2014
From: JAKOBSEN, BENT KARSTEN; ANDERSEN, TORBEN BENT; MOLLOY, PETER EAMON; LI, YI
To: AVIDEX LIMITED
Reel/Frame 032658/0612 →
Change of Name
Apr 11, 2014
From: AVIDEX LIMITED
To: MEDIGENE LIMITED
Reel/Frame 032658/0776 →
Assignment of Assignor's Interest
Apr 14, 2014
From: IMMUNOCORE LIMITED
To: ADAPTIMMUNE LIMITED
Reel/Frame 032662/0815 →
Assignment of Assignor's Interest
Apr 14, 2014
From: MEDIGENE LIMITED
To: IMMUNOCORE LIMITED
Reel/Frame 032662/0754 →
Corrective Assignment to Correct the Assignees Previously Recorded at Reel: 032662 Frame: 0815. Assignor(S) Hereby Confirms the Assignment.
Jun 10, 2014
From: IMMUNOCORE LIMITED
To: IMMUNOCORE LIMITED; ADAPTIMMUNE LIMITED
Reel/Frame 033109/0597 →